Genmab — Juni 2017
-
Darvin..Enig.
-
Der er tale om fase I/II, så dosering er på plads - vi er videre i teksten
-
men mon ikke SGEN vil se readouts på de andre indikationer. Så beslutning om opt-in eller -out kommer først når alle data er inde et sted mellem Q3 og Q4?
-
Genmab Research & Development Center in Utrecht delivered, looks like the interior designer still has a little bit of work... http://image-store.slidesharecdn.com/d0f396ef-b2d2-4768-a025-3fa247b1658d-original.jpeg
-
Proinvestorchatten skal da på besøg. Hvor mange er friske?
-
-
God morgen.

-
Tusinde tak Sukkealf.
-
Jeg snakker med Rachel omkring en tur til Utrect.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
